Tempus AI
Links clinical testing, multimodal data, and AI applications across precision medicine.
$63.44
After-hours close−0.57 (−0.89%)
At close$64.01(−9.45%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 67.54%118.34M sharesInsiders 2.11%3.69M sharesOther 30.35%53.17M shares
Shares outstanding 175.20M · Float 106.50M · 60.8% free float
Institutions13F, as of Jun 30, 2026
541 holders · 118.34M shares · 126 new positions · 291 increased · 131 reduced · 59 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ark Investment Management LLC | 10.02M | 5.72% | +414.9K | Aug 14, 2026 |
| BlackRock, Inc. | 8.29M | 4.73% | −677.3K | Aug 7, 2026 |
| Baillie Gifford & Co | 8.19M | 4.67% | −459.2K | Aug 6, 2026 |
| SoftBank Group Corp. | 5.41M | 3.09% | 0 | Aug 14, 2026 |
| JPMorgan Chase & Co | 4.99M | 2.85% | +55.9K | Aug 12, 2026 |
| Vanguard Capital Management LLC | 4.99M | 2.85% | +69.9K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 4.91M | 2.81% | +235.4K | Aug 13, 2026 |
| Sumitomo Mitsui Trust Group, Inc. | 4.09M | 2.33% | −237.3K | Jul 30, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Eric Paul Lefkofsky | 24.00% | 42.77M | 13G | Feb 10, 2026 ↗ |
| Bradley A. Keywell | 7.60% | 12.85M | 13G | May 15, 2025 ↗ |
| ARK Investment Management LLC | 5.44% | 9.45M | 13G | Mar 6, 2026 ↗ |
| Baillie Gifford & Co | 5.00% | 8.65M | 13G | May 7, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Eric P. Lefkofsky | director, 10 percent owner, officer: CEO and Chairman | 2.25M | 1.28% | Aug 27, 2026 |
| Ryan Fukushima | officer: CEO, Data | 609.9K | 0.35% | Aug 25, 2026 |
| Andrew Polovin | officer: EVP, Chief Legal Officer | 138.1K | 0.08% | Aug 20, 2026 |
| Peter J. Barris | director | 121.4K | 0.07% | May 26, 2026 |
| James William Rogers | officer: Chief Financial Officer | 106.0K | 0.06% | Aug 20, 2026 |
| Thomas Edward Schoenherr | officer: CEO, Diagnostics | 87.0K | 0.05% | Aug 25, 2026 |
| Theodore Leonsis | director | 80.3K | 0.05% | Aug 28, 2025 |
| Erik Phelps | officer: EVP, Chief Admin. Officer | 79.8K | 0.05% | Feb 20, 2026 |
| Ryan M. Bartolucci | officer: Chief Accounting Officer | 67.9K | 0.04% | Aug 20, 2026 |
| Nadja West | director | 35.0K | 0.02% | Aug 18, 2026 |
2 ten-percent owners hold 46.39M shares by Form 4, outside the officers-and-directors figure above · 2 people have not refiled in the last 18 months (753.2K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 25, 2026 | Eric P. Lefkofskydirector, 10 percent owner, officer: CEO and Chairman | Sale · 32 lots | 250,000 | $68.46 | 150,000 |
| Aug 21, 2026 | Ryan Fukushimaofficer: CEO, Data | Sale | 14,286 | $70.00 | 47,420 |
| Aug 21, 2026 | Thomas Edward Schoenherrofficer: CEO, Diagnostics | Sale | 2,694 | $70.00 | 87,021 |
| Aug 18, 2026 | Ryan M. Bartolucciofficer: Chief Accounting Officer | Sale | 6,175 | $49.61 | 67,866 |
| Aug 19, 2026 | Andrew Polovinofficer: EVP, Chief Legal Officer | Sale | 7,927 | $56.00 | 138,140 |
| Aug 18, 2026 | Andrew Polovinofficer: EVP, Chief Legal Officer | Sale | 22,148 | $49.61 | 146,067 |
| Aug 19, 2026 | James William Rogersofficer: Chief Financial Officer | Sale | 26,313 | $60.00 | 106,024 |
| Aug 18, 2026 | James William Rogersofficer: Chief Financial Officer | Sale | 22,529 | $49.61 | 132,337 |
| Aug 19, 2026 | Thomas Edward Schoenherrofficer: CEO, Diagnostics | Sale · 6 lots | 8,082 | $58.40 | 89,715 |
| Aug 18, 2026 | Thomas Edward Schoenherrofficer: CEO, Diagnostics | Sale | 9,232 | $49.61 | 97,797 |
CongressHouse and Senate disclosures
Not reported.